Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision was updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:08:57.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; Removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:52:52.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed Revision: v3.4.1 notice about government funding and operating status.
    Difference
    0.4%
    Check dated 2026-02-11T12:14:27.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status was added. The page version was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:46:30.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Glossary display was added, and metadata labels were updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act Data', and revision note v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-28T04:52:10.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No other content changes were observed.
    Difference
    0.1%
    Check dated 2026-01-14T02:36:27.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.